Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity.

Literature DB >> 14659467

T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity.

Volker Schirrmacher¹, Markus Feuerer, Philippe Fournier, Thorsten Ahlert, Viktor Umansky, Philipp Beckhove.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 14659467 DOI： 10.1016/j.molmed.2003.10.001

Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

1. Significance of heparanase in cancer and inflammation.

Authors: Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal: Cancer Microenviron Date: 2011-08-03

2. CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia.

Authors: Christina Arieta Kuksin; Gabriela Gonzalez-Perez; Lisa M Minter
Journal: Blood Date: 2015-02-03 Impact factor: 22.113

3. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.

Authors: Christoph Reissfelder; Slava Stamova; Christina Gossmann; Marion Braun; Andreas Bonertz; Ute Walliczek; Mario Grimm; Nuh N Rahbari; Moritz Koch; Maral Saadati; Axel Benner; Markus W Büchler; Dirk Jäger; Niels Halama; Khashayarsha Khazaie; Jürgen Weitz; Philipp Beckhove
Journal: J Clin Invest Date: 2014-12-22 Impact factor: 14.808

4. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.

Authors: Patrizia Leone; Simona Berardi; Maria Antonia Frassanito; Roberto Ria; Valli De Re; Sebastiano Cicco; Stefano Battaglia; Paolo Ditonno; Franco Dammacco; Angelo Vacca; Vito Racanelli
Journal: Blood Date: 2015-07-16 Impact factor: 22.113

5. Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.

Authors: Ines A Silva; Krystyna Olkiewicz; David Askew; Jacquelyn M Fisher; Meghana N Chaudhary; Kevin M Vannella; Daphne T Deurloo; Sung W Choi; Elizabeth M Pierce; Shawn G Clouthier; Chen Liu; Kenneth R Cooke
Journal: Biol Blood Marrow Transplant Date: 2010-02-01 Impact factor: 5.742

Review 6. Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy.

Authors: Christoph Domschke; Andreas Schneeweiss; Stefan Stefanovic; Markus Wallwiener; Joerg Heil; Joachim Rom; Christof Sohn; Philipp Beckhove; Florian Schuetz
Journal: Breast Care (Basel) Date: 2016-04-27 Impact factor: 2.860

7. Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.

Authors: Friedrich H Schmitz-Winnenthal; Nicolas Hohmann; Andreas G Niethammer; Tobias Friedrich; Heinz Lubenau; Marco Springer; Klaus M Breiner; Gerd Mikus; Jürgen Weitz; Alexis Ulrich; Markus W Buechler; Frank Pianka; Ulla Klaiber; Markus Diener; Christine Leowardi; Simon Schimmack; Leila Sisic; Anne-Valerie Keller; Ruhan Koc; Christoph Springfeld; Philipp Knebel; Thomas Schmidt; Yingzi Ge; Mariana Bucur; Slava Stamova; Lilli Podola; Walter E Haefeli; Lars Grenacher; Philipp Beckhove
Journal: Oncoimmunology Date: 2015-03-16 Impact factor: 8.110